Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate
The NM_000548.5(TSC2):c.5050T>C(p.Ser1684Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1684A) has been classified as Pathogenic.
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Verdict is Pathogenic. Variant got 10 ACMG points.
PM1
In a domain Rap-GAP (size 227) in uniprot entity TSC2_HUMAN there are 284 pathogenic changes around while only 47 benign (86%) in NM_000548.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-2087923-T-G is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.86
PP5
Variant 16-2087923-T-C is Pathogenic according to our data. Variant chr16-2087923-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 49343.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr16-2087923-T-C is described in Lovd as [Pathogenic]. Variant chr16-2087923-T-C is described in Lovd as [Pathogenic].
Likely pathogenic, criteria provided, single submitter
clinical testing
Athena Diagnostics
Feb 23, 2024
This variant has been identified in several individuals with clinical features associated with this gene and appears to occur de novo in at least one individual. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) Assessment of experimental evidence suggests this variant results in abnormal protein function. (personal communication related to LOVD BD-ID: TSC2_000888) -